ClinicalTrials.Veeva

Menu

Study on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical Bioinformatics

W

Wenzhou Medical University

Status

Unknown

Conditions

Chronic Obstructive Pulmonary Disease

Study type

Observational

Funder types

Other

Identifiers

NCT05069194
2016YFC1304000

Details and patient eligibility

About

The risk factors and causes of chronic obstructive pulmonary disease(COPD)are not clear, so the prevalence of COPD is high and the prevention effect is not good. Because the pathogenesis of COPD is not completely elucidated, the diagnosis and classification of COPD are inaccurate which resulting in poor efficacy of treatment. Therefore, it is of great scientific and clinical significance to find out the risk factors and causes of COPD, to clarify its pathogenesis, to put forward the prevention and early intervention measures of COPD, to warn the occurrence of COPD, to predict the deterioration of the disease, to reduce the occurrence of COPD and to slow down the progress of COPD.

The project establishes a cohort of COPD people,high-risk group and the healthy group. The project studys the risk factors, etiology and pathogenesis of COPD. The project studys the interaction between genetic factors and environmental factors on COPD and its effect on pathogenesis, progression and outcome of COPD.

Full description

The project establishes the data base and specimen bank for COPD.Then clinical bioinformatics technology is uesd to analyze the clinical information and epidemiological information. In the same time, Omics methods are used to study COPD-related genes and biomarkers . Finally, a multi-factor risk factor model for the occurrence and development of COPD is established by combining clinical information, epidemiological information and biomics results.

Enrollment

13,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

① Inclusion criteria for patients with COPD:

  • Over 18 years of age.

  • FEV1 / FVC< 70% was the diagnostic criterion for COPD after inhaling bronchodilators.

    ② Inclusion criteria for high-risk subjects:

  • Over 18 years of age.

  • Physical examination and routine laboratory tests were normal.

  • Chest CT to exclude other pulmonary diseases.

  • Lung function does not meet the diagnostic criteria for COPD.

  • having one of the following risk factors: A. Smoking: current smokers, smoking index (number of years of smoking × number of cigarettes per day)≥ L.

B. Biofuel exposure: Subjects frequently use charcoal, wood, and animal dung for home heating and cooking Or crops are defined as having a history of exposure to biofuels. C. Dust and chemical exposure: mining, quarrying, casting, grain dust, paint, chemicals and others (including non-return) In the above categories of self-reported) occupational dust or gas smoke exposure for more than 1 year.

③ Inclusion criteria of healthy control subjects:

  • Over 18 years of age.
  • Physical examination and routine laboratory tests were normal.
  • Chest CT to exclude other pulmonary diseases.
  • Lung function does not meet the diagnostic criteria for COPD.
  • No risk factors (including smoking, biofuel exposure, dust or chemical exposure).

Exclusion criteria

  • History of other chronic lung diseases, such as bronchiectasis, pulmonary interstitial fibrosis, etc.
  • History of acute lung disease within 3 months.
  • History of malignant tumor.
  • Pregnant and lactating women.

Trial design

13,000 participants in 3 patient groups

COPD
Description:
Patients with chronic obstructive pulmonary disease
High Risk
Description:
People who do not suffer from COPD, but have high risk factor for COPD.
Health
Description:
People who do not suffer from COPD and do not have a high risk factor for COPD either.

Trial contacts and locations

1

Loading...

Central trial contact

Li Yang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems